{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-1981-N-0042\" and posted_year = 2016 sorted by posted_date descending", "rows": [["FDA-1981-N-0042-0051", "FDA", "FDA-1981-N-0042", "Petition Denial Letter from FDA ORA to Olsson Frank & Weeda, PC", "Other", "Denial", "2016-09-13T04:00:00Z", 2016, 9, "2016-09-13T04:00:00Z", null, "2016-09-13T16:38:25Z", null, 0, 0, "09000064805af2b3"], ["FDA-1981-N-0042-0048", "FDA", "FDA-1981-N-0042", "Attachment 2 Memo to DDM re: Correction from Schering-Plough HealthCare Products (Sinofresh Research Labs, LLC)", "Supporting & Related Material", "Background Material", "2016-09-13T04:00:00Z", 2016, 9, null, null, "2016-09-13T16:06:35Z", null, 0, 0, "09000064822052e2"], ["FDA-1981-N-0042-0043", "FDA", "FDA-1981-N-0042", "Acknowledgment Letter from FDA DDM to Olsson, Frank, & Weeda, LLC", "Other", "Acknowledgement Letter/Receipt", "2016-09-13T04:00:00Z", 2016, 9, "2016-09-13T04:00:00Z", null, "2016-09-13T14:00:19Z", null, 0, 0, "09000064805af2ad"], ["FDA-1981-N-0042-0044", "FDA", "FDA-1981-N-0042", "Supplement from Olsson, Frank, & Weeda, P.C. (Sinofresh Research Labs, LLC)", "Supporting & Related Material", "Background Material", "2016-09-13T04:00:00Z", 2016, 9, null, null, "2016-09-13T14:10:28Z", null, 0, 0, "09000064805af2ae"], ["FDA-1981-N-0042-0047", "FDA", "FDA-1981-N-0042", "Attachment 1 Sinofresh Company Information re: Correction from Schering-Plough HealthCare Products (Sinofresh Research Labs, LLC)", "Supporting & Related Material", "Background Material", "2016-09-13T04:00:00Z", 2016, 9, null, null, "2016-09-13T16:00:56Z", null, 0, 0, "09000064822052e1"], ["FDA-1981-N-0042-0050", "FDA", "FDA-1981-N-0042", "Attachment 4 Examples of Radio Advertisement re: Correction from Schering-Plough HealthCare Products (Sinofresh Research Labs, LLC)", "Supporting & Related Material", "Background Material", "2016-09-13T04:00:00Z", 2016, 9, null, null, "2016-09-13T16:26:31Z", null, 0, 0, "09000064822052e4"], ["FDA-1981-N-0042-0046", "FDA", "FDA-1981-N-0042", "Correction from Schering-Plough HealthCare Products (Sinofresh Research Labs, LLC)", "Other", "Correction(s)", "2016-09-13T04:00:00Z", 2016, 9, "2016-09-13T04:00:00Z", null, "2016-09-13T15:56:00Z", null, 0, 0, "09000064805af2b2"], ["FDA-1981-N-0042-0049", "FDA", "FDA-1981-N-0042", "Attachment 3 Product Information on Sinofresh re: Correction from Schering-Plough HealthCare Products (Sinofresh Research Labs, LLC)", "Supporting & Related Material", "Background Material", "2016-09-13T04:00:00Z", 2016, 9, null, null, "2016-09-13T16:23:10Z", null, 0, 0, "09000064822052e3"], ["FDA-1981-N-0042-0040", "FDA", "FDA-1981-N-0042", "List of References re: Citizen Petition from Olsson, Frank, and Weeda, P.C. (Sinofresh Research Labs, LLC)", "Supporting & Related Material", "Background Material", "2016-09-12T04:00:00Z", 2016, 9, null, null, "2016-09-12T17:32:36Z", null, 0, 0, "09000064805af2a3"], ["FDA-1981-N-0042-0042", "FDA", "FDA-1981-N-0042", "Attachment 10 Weaver, A. et al. Mouthwash and oral cancer: carcinogen or coincidence? J. Oral Surg. 37:250-253, 1979. re: Citizen Petition from Olsson, Frank, and Weeda, P.C. (Sinofresh Research Labs, LLC)", "Supporting & Related Material", "Background Material", "2016-09-12T04:00:00Z", 2016, 9, null, null, "2016-09-12T19:10:29Z", null, 0, 0, "09000064805af2a7"], ["FDA-1981-N-0042-0038", "FDA", "FDA-1981-N-0042", "Letter from FDA CDER to Colgate-Palmolive Company", "Other", "Letter(s)", "2016-09-12T04:00:00Z", 2016, 9, "2016-09-12T04:00:00Z", null, "2016-09-12T16:52:37Z", null, 0, 0, "09000064805af298"], ["FDA-1981-N-0042-0037", "FDA", "FDA-1981-N-0042", "Supplement from SmithKline Beecham Consumer Healthcare", "Supporting & Related Material", "Background Material", "2016-09-12T04:00:00Z", 2016, 9, null, null, "2016-09-12T16:10:20Z", null, 0, 0, "09000064805af296"], ["FDA-1981-N-0042-0041", "FDA", "FDA-1981-N-0042", "Attachment 9 Robinson, R.F. The effect of quaternary ammonium compounds on oral bacteria: An in vivo study using cetylpyridinium chloride.  J. Dent. Ass. S. Afr. 25:68-74, 1970. re: Citizen Petition from Olsson, Frank, and Weeda, P.C. (Sinofresh Research Labs, LLC)", "Supporting & Related Material", "Background Material", "2016-09-12T04:00:00Z", 2016, 9, null, null, "2016-09-12T19:05:15Z", null, 0, 0, "09000064805af2aa"], ["FDA-1981-N-0042-0039", "FDA", "FDA-1981-N-0042", "Citizen Petition from Olsson, Frank, and Weeda, P.C. (Sinofresh Research Labs, LLC)", "Other", "Citizen Petition", "2016-09-12T04:00:00Z", 2016, 9, "2016-09-12T04:00:00Z", null, "2016-09-14T01:01:20Z", null, 0, 0, "09000064805af2a2"], ["FDA-1981-N-0042-0031", "FDA", "FDA-1981-N-0042", "Supplement from Procter & Gamble Company", "Supporting & Related Material", "Background Material", "2016-09-06T04:00:00Z", 2016, 9, null, null, "2016-09-06T15:37:46Z", null, 0, 0, "09000064805af291"], ["FDA-1981-N-0042-0035", "FDA", "FDA-1981-N-0042", "Report from Ciba Specialty Chemicals Corporation", "Supporting & Related Material", "Background Material", "2016-09-06T04:00:00Z", 2016, 9, null, null, "2016-09-06T18:27:50Z", null, 0, 0, "09000064805af299"], ["FDA-1981-N-0042-0034", "FDA", "FDA-1981-N-0042", "Memorandum of Meeting Minutes", "Other", "Minutes", "2016-09-06T04:00:00Z", 2016, 9, "2016-09-06T04:00:00Z", null, "2016-09-06T16:35:45Z", null, 0, 0, "09000064805af29a"], ["FDA-1981-N-0042-0033", "FDA", "FDA-1981-N-0042", "Protocol Study \"Peroxyl Rinse Study 00194: Microbiological Testing\" from Colgate-Palmolive Company", "Other", "Protocol Review", "2016-09-06T04:00:00Z", 2016, 9, "2016-09-06T04:00:00Z", null, "2016-09-06T16:19:22Z", null, 0, 0, "09000064805af297"], ["FDA-1981-N-0042-0032", "FDA", "FDA-1981-N-0042", "Request for Meeting from Colgate-Palmolive Company", "Other", "Request", "2016-09-06T04:00:00Z", 2016, 9, "2016-09-06T04:00:00Z", null, "2016-09-06T15:51:50Z", null, 0, 0, "09000064805af294"], ["FDA-1981-N-0042-0025", "FDA", "FDA-1981-N-0042", "Attachments XXXI - XXXII Articles from FDA re: Comment from Warner-Lambert Company", "Supporting & Related Material", "Background Material", "2016-09-02T04:00:00Z", 2016, 9, null, null, "2016-09-02T16:18:17Z", null, 0, 0, "09000064821c388c"], ["FDA-1981-N-0042-0027", "FDA", "FDA-1981-N-0042", "Attachment XXXIX Minah et al Effects of 6 Months Use of an Antiseptic Mouthrinse on Supragingival Dental plaque Microflora. J. Clin. Periodontol; 16: 347-352, 1990. re: Comment from Warner-Lambert Company", "Supporting & Related Material", "Background Material", "2016-09-02T04:00:00Z", 2016, 9, null, null, "2016-09-02T16:40:07Z", null, 0, 0, "09000064821c38e7"], ["FDA-1981-N-0042-0028", "FDA", "FDA-1981-N-0042", "Attachment XLIV Warner-Lambert Company Presentation on Alcohol to Dental Products Plaque Subcommittee June 28, 1994. re: Comment from Warner-Lambert Company", "Supporting & Related Material", "Background Material", "2016-09-02T04:00:00Z", 2016, 9, null, null, "2016-09-02T16:48:57Z", null, 0, 0, "09000064821c38e9"], ["FDA-1981-N-0042-0022", "FDA", "FDA-1981-N-0042", "Attachment XXIV Pianotti and Pitts Effects of an Antiseptic Mouthwash on Odorigenic Microbes in the Human Gingival Crevice J. Dent. Res., Vol 57: 175-179 February 1978.  re: Comment from Warner-Lambert Company", "Supporting & Related Material", "Background Material", "2016-09-02T04:00:00Z", 2016, 9, null, null, "2016-09-02T15:36:50Z", null, 0, 0, "09000064821bea4c"], ["FDA-1981-N-0042-0024", "FDA", "FDA-1981-N-0042", "Attachment XXIX - XXX Cited References re: Comment from Warner-Lambert Company", "Supporting & Related Material", "Background Material", "2016-09-02T04:00:00Z", 2016, 9, null, null, "2016-09-02T16:05:09Z", null, 0, 0, "09000064821bea50"], ["FDA-1981-N-0042-0021", "FDA", "FDA-1981-N-0042", "Attachment XXII Letter from Covington & Burling to FDA CDER re: Comment from Warner-Lambert Company", "Supporting & Related Material", "Background Material", "2016-09-02T04:00:00Z", 2016, 9, null, null, "2016-09-02T15:26:23Z", null, 0, 0, "09000064821be97e"], ["FDA-1981-N-0042-0023", "FDA", "FDA-1981-N-0042", "Attachment XXVI Pianotti and Pitts Effects of an Antispetic Mouthwash on Odorigenic Microbes in the Human Gingival Crevice. J. dent Res., Vol 57: 175-179 February 1978. re: Comment from Warner-Lambert Company", "Supporting & Related Material", "Background Material", "2016-09-02T04:00:00Z", 2016, 9, null, null, "2016-09-02T15:50:08Z", null, 0, 0, "09000064821bea4e"], ["FDA-1981-N-0042-0026", "FDA", "FDA-1981-N-0042", "Attachment XXXVII Overholser et al Comparative Effects of 2 Chemotherapeutic Mouthrinses on the Development of Supragingival Dental Plaque and Gingivitis. J. Clin Periodontol; 17: 575-579 September 1990. re: Comment from Warner-Lambert Company", "Supporting & Related Material", "Background Material", "2016-09-02T04:00:00Z", 2016, 9, null, null, "2016-09-02T16:33:01Z", null, 0, 0, "09000064821c388f"], ["FDA-1981-N-0042-0029", "FDA", "FDA-1981-N-0042", "Attachment XLV Mouthwash Use and Oropharyngeal Cancer, Presentation by Dr. Samuel Shapiro to Dental Products Plaque Subcommittee June 28, 1994 re: Comment from Warner-Lambert Company", "Supporting & Related Material", "Background Material", "2016-09-02T04:00:00Z", 2016, 9, null, null, "2016-09-02T16:54:17Z", null, 0, 0, "09000064821c38ea"], ["FDA-1981-N-0042-0020", "FDA", "FDA-1981-N-0042", "Attachment XV Slade, H.D. The Anti-Streptococcal Activity of Listerine. Warner-Lambert Research Institute Report. August 1961. re: Comment from Warner-Lambert Company", "Supporting & Related Material", "Background Material", "2016-08-31T04:00:00Z", 2016, 8, null, null, "2016-08-31T13:05:31Z", null, 0, 0, "09000064821b274f"], ["FDA-1981-N-0042-0019", "FDA", "FDA-1981-N-0042", "Attachment XIV Reddish, G.F. In Vivo Bacterial Reductions Following the Use of Various Oral Hygiene Products. December 3, 1951 re: Comment from Warner-Lambert Company", "Supporting & Related Material", "Background Material", "2016-08-31T04:00:00Z", 2016, 8, null, null, "2016-08-31T12:59:37Z", null, 0, 0, "09000064821b274e"], ["FDA-1981-N-0042-0013", "FDA", "FDA-1981-N-0042", "List of Attachments re: Comment from Warner-Lambert Company", "Supporting & Related Material", "Background Material", "2016-08-30T04:00:00Z", 2016, 8, null, null, "2016-08-30T18:30:42Z", null, 0, 0, "09000064821a157f"], ["FDA-1981-N-0042-0014", "FDA", "FDA-1981-N-0042", "Attachment VII Fine, D.H. et al Reducing Bacteria in Dental Aerosols: Pre-Procedural Use of an Antiseptic Mouthrinse. JADA: Vol. 124, May 1993. re: Comment from Warner-Lambert Company", "Supporting & Related Material", "Background Material", "2016-08-30T04:00:00Z", 2016, 8, null, null, "2016-08-30T18:46:52Z", null, 0, 0, "09000064821b25d5"], ["FDA-1981-N-0042-0017", "FDA", "FDA-1981-N-0042", "Attachment XI Campbell, W.C. Listerine's Effectiveness in Reducing Oral Bacterial Counts. October 4, 1932 re: Comment from Warner-Lambert Company", "Supporting & Related Material", "Background Material", "2016-08-30T04:00:00Z", 2016, 8, null, null, "2016-08-30T19:03:02Z", null, 0, 0, "09000064821b274b"], ["FDA-1981-N-0042-0015", "FDA", "FDA-1981-N-0042", "Attachment IX Fine, D., et al Reduction of Viable Bacteria in Dental Aerosols by Preprocedural Rinsing with an Antiseptic Mouthrinse. AJD, Vol. 6, October 1993, re: Comment from Warner-Lambert Company", "Supporting & Related Material", "Background Material", "2016-08-30T04:00:00Z", 2016, 8, null, null, "2016-08-30T18:56:12Z", null, 0, 0, "09000064821b2749"], ["FDA-1981-N-0042-0018", "FDA", "FDA-1981-N-0042", "Attachment XIII Reddish, G.F. Bacterial Reductions in the Oral Cavity and the Throat. 1941 re: Comment from Warner-Lambert Company", "Supporting & Related Material", "Background Material", "2016-08-30T04:00:00Z", 2016, 8, null, null, "2016-08-30T19:13:26Z", null, 0, 0, "09000064821b274d"], ["FDA-1981-N-0042-0016", "FDA", "FDA-1981-N-0042", "Attachment X Hunter, O.B. The In Vitro Germicidal Properties of Listerine. 1932. re: Comment from Warner-Lambert Company", "Supporting & Related Material", "Background Material", "2016-08-30T04:00:00Z", 2016, 8, null, null, "2016-08-30T18:59:21Z", null, 0, 0, "09000064821b274a"], ["FDA-1981-N-0042-0010", "FDA", "FDA-1981-N-0042", "FDA. 1982. Oral health care drug products for over-the-counter human use; proposed rules for oral antiseptic drug products. 47 FR 22760 at 22890-91. re: Comment from Procter & Gamble Company", "Supporting & Related Material", "Background Material", "2016-08-26T04:00:00Z", 2016, 8, null, null, "2016-08-26T15:23:15Z", null, 0, 0, "09000064805af28d"], ["FDA-1981-N-0042-0011", "FDA", "FDA-1981-N-0042", "Lumpkin, M.M. 1993. Microbiology labeling information letter to NDA holders, Division of\nAnti-Infective Drug Products, Center for Drug Evaluation and Research. re: Comment from Procter & Gamble Company", "Supporting & Related Material", "Background Material", "2016-08-26T04:00:00Z", 2016, 8, null, null, "2016-08-26T15:55:27Z", null, 0, 0, "09000064821a0a19"], ["FDA-1981-N-0042-0009", "FDA", "FDA-1981-N-0042", "List of References re: Comment from Procter & Gamble Company", "Supporting & Related Material", "Background Material", "2016-08-26T04:00:00Z", 2016, 8, null, null, "2016-08-26T14:48:12Z", null, 0, 0, "090000648219fcd5"], ["FDA-1981-N-0042-0002", "FDA", "FDA-1981-N-0042", "Oral Health Care Drug Products for Over-the-Counter Human Use; Tentative Final Monograph for Oral Antiseptic Drug Products", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2016-08-25T04:00:00Z", 2016, 8, "1994-02-09T05:00:00Z", "1994-08-09T03:59:59Z", "2016-09-17T18:58:24Z", "94-2262", 0, 0, "09000064805af28a"], ["FDA-1981-N-0042-0006", "FDA", "FDA-1981-N-0042", "Reference 4 Memorandum of Telephone Conversation re: Oral Health Care Drug Products for Over-the-Counter Human Use; Tentative Final Monograph for Oral Antiseptic Drug Products", "Supporting & Related Material", "Background Material", "2016-08-25T04:00:00Z", 2016, 8, null, null, "2016-08-25T19:52:17Z", null, 0, 0, "090000648219de77"], ["FDA-1981-N-0042-0007", "FDA", "FDA-1981-N-0042", "Reference 5 Adverse Reaction Printouts re: Oral Health Care Drug Products for Over-the-Counter Human Use; Tentative Final Monograph for Oral Antiseptic Drug Products", "Supporting & Related Material", "Background Material", "2016-08-25T04:00:00Z", 2016, 8, null, null, "2016-08-25T20:08:41Z", null, 0, 0, "090000648219de78"], ["FDA-1981-N-0042-0003", "FDA", "FDA-1981-N-0042", "Published Federal Register Notice 59FR6084 \"Oral Health Care Drug Products for Over-the-Counter Human Use; Tentative Final Monograph for Oral Antiseptic Drug Products\"", "Supporting & Related Material", "Background Material", "2016-08-25T04:00:00Z", 2016, 8, null, null, "2016-08-25T16:54:47Z", null, 0, 0, "09000064805af2b0"], ["FDA-1981-N-0042-0004", "FDA", "FDA-1981-N-0042", "Table of Contents References re: Oral Health Care Drug Products for Over-the-Counter Human Use; Tentative Final Monograph for Oral Antiseptic Drug Products", "Supporting & Related Material", "Background Material", "2016-08-25T04:00:00Z", 2016, 8, null, null, "2016-08-25T16:59:17Z", null, 0, 0, "090000648219cfa8"], ["FDA-1981-N-0042-0005", "FDA", "FDA-1981-N-0042", "Reference 3 Memorandum of Meeting re: Oral Health Care Drug Products for Over-the-Counter Human Use; Tentative Final Monograph for Oral Antiseptic Drug Products", "Supporting & Related Material", "Background Material", "2016-08-25T04:00:00Z", 2016, 8, null, null, "2016-08-25T19:48:25Z", null, 0, 0, "090000648219de76"]], "truncated": false, "filtered_table_rows_count": 45, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA-1981-N-0042", "p1": "2016"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1981-N-0042&posted_year=2016", "results": [{"value": "FDA", "label": "FDA", "count": 45, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1981-N-0042&posted_year=2016&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1981-N-0042&posted_year=2016", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 36, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1981-N-0042&posted_year=2016&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 8, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1981-N-0042&posted_year=2016&document_type=Other", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1981-N-0042&posted_year=2016&document_type=Proposed+Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1981-N-0042&posted_year=2016", "results": [{"value": 2016, "label": 2016, "count": 45, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1981-N-0042", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1981-N-0042&posted_year=2016&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1981-N-0042&posted_year=2016&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1981-N-0042&posted_year=2016&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1981-N-0042&posted_year=2016&_facet=comment_start_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1981-N-0042&posted_year=2016&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1981-N-0042&posted_year=2016&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1981-N-0042&posted_year=2016&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1981-N-0042&posted_year=2016&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 781.403282948304, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}